🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Stavanger University Hospital Inflammatory Bowel Disease Trial

Recruitingn/aAges 16 Years - 80 YearsAllHelse Stavanger HF
NCT01551563 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * newly diagnosed IBD Exclusion Criteria: * previous IBD with specific treatment within 10 year * inability to consent * inability to adhere to treatment protocol
💊

What it tests

  • Not listed
📍

Where

1 site
SUS
Stavanger, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy